Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $9.19 billion. The enterprise value is $9.28 billion.
| Market Cap | 9.19B |
| Enterprise Value | 9.28B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 135.05 million shares outstanding. The number of shares has increased by 32.45% in one year.
| Shares Outstanding | 135.05M |
| Shares Change (YoY) | +32.45% |
| Shares Change (QoQ) | +5.46% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 102.84% |
| Float | 111.66M |
Valuation Ratios
The trailing PE ratio is 109.76 and the forward PE ratio is 23.19. Globus Medical's PEG ratio is 1.75.
| PE Ratio | 109.76 |
| Forward PE | 23.19 |
| PS Ratio | 4.84 |
| Forward PS | 3.59 |
| PB Ratio | 2.34 |
| P/FCF Ratio | 60.57 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.19, with an EV/FCF ratio of 61.18.
| EV / Earnings | 139.31 |
| EV / Sales | 4.89 |
| EV / EBITDA | 35.19 |
| EV / EBIT | 113.32 |
| EV / FCF | 61.18 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.33 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.99 |
| Debt / FCF | 3.46 |
| Interest Coverage | -6.98 |
Financial Efficiency
Return on equity (ROE) is 1.90% and return on invested capital (ROIC) is 1.36%.
| Return on Equity (ROE) | 1.90% |
| Return on Assets (ROA) | 1.50% |
| Return on Capital (ROIC) | 1.36% |
| Revenue Per Employee | $379,691 |
| Profits Per Employee | $13,325 |
| Employee Count | 5,000 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, Globus Medical has paid $27.02 million in taxes.
| Income Tax | 27.02M |
| Effective Tax Rate | 28.85% |
Stock Price Statistics
The stock price has increased by +17.07% in the last 52 weeks. The beta is 1.15, so Globus Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +17.07% |
| 50-Day Moving Average | 62.39 |
| 200-Day Moving Average | 54.04 |
| Relative Strength Index (RSI) | 64.03 |
| Average Volume (20 Days) | 1,003,636 |
Short Selling Information
The latest short interest is 6.86 million, so 5.08% of the outstanding shares have been sold short.
| Short Interest | 6.86M |
| Short Previous Month | 7.18M |
| Short % of Shares Out | 5.08% |
| Short % of Float | 6.14% |
| Short Ratio (days to cover) | 8.24 |
Income Statement
In the last 12 months, Globus Medical had revenue of $1.90 billion and earned $66.63 million in profits. Earnings per share was $0.62.
| Revenue | 1.90B |
| Gross Profit | 1.18B |
| Operating Income | 84.74M |
| Pretax Income | 93.65M |
| Net Income | 66.63M |
| EBITDA | 263.79M |
| EBIT | 81.91M |
| Earnings Per Share (EPS) | $0.62 |
Balance Sheet
The company has $434.47 million in cash and $525.60 million in debt, giving a net cash position of -$91.13 million or -$0.67 per share.
| Cash & Cash Equivalents | 434.47M |
| Total Debt | 525.60M |
| Net Cash | -91.13M |
| Net Cash Per Share | -$0.67 |
| Equity (Book Value) | 3.92B |
| Book Value Per Share | 29.04 |
| Working Capital | 1.04B |
Cash Flow
In the last 12 months, operating cash flow was $242.57 million and capital expenditures -$90.85 million, giving a free cash flow of $151.72 million.
| Operating Cash Flow | 242.57M |
| Capital Expenditures | -90.85M |
| Free Cash Flow | 151.72M |
| FCF Per Share | $1.12 |
Margins
Gross margin is 62.14%, with operating and profit margins of 4.46% and 3.51%.
| Gross Margin | 62.14% |
| Operating Margin | 4.46% |
| Pretax Margin | 4.93% |
| Profit Margin | 3.51% |
| EBITDA Margin | 13.90% |
| EBIT Margin | 4.31% |
| FCF Margin | 7.99% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.45% |
| Shareholder Yield | -32.45% |
| Earnings Yield | 0.72% |
| FCF Yield | 1.65% |
Analyst Forecast
The average price target for Globus Medical is $69.40, which is 1.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $69.40 |
| Price Target Difference | 1.98% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 17.59% |
| EPS Growth Forecast (5Y) | 37.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 6.39 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.39 |
| Piotroski F-Score | 4 |